Source: Annual Congress 2004 - Arginase: a novel target and marker for asthma?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Racke (Bonn, Germany). Arginase in airway inflammation and remodelling. Annual Congress 2004 - Arginase: a novel target and marker for asthma?

Member's Comments

No comment yet.

Related content which might interest you: Allergen-induced airway remodelling Source: Eur Respir J 2007; 29: 1020-1032 Year: 2007 Airway inflammatory mediators and airway wall remodelling in asthma Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Increased arginase activity contributes to airway remodelling in chronic allergic asthma Source: Eur Respir J 2011; 38: 318-328 Year: 2011 Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Aerobic exercise reduces allergic airway inflammation and remodeling by deactivating airway epithelial cells and leukocytes Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Continuous airway inflammation is related to the development of airway remodeling Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 Inflammatory cells and airway remodelling in COPD Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 The role of small-airway inflammation and remodeling in asthma Source: Annual Congress 2013 –Small airways in asthma: from physiologic measures to clinical relevance Year: 2013 Inhaled insulin does not trigger lung inflammation and airway remodelling Source: Eur Respir J 2009; 33: 444-445 Year: 2009 ADAM-8 metalloproteinase drives acute allergen-induced airway inflammation Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Neurokinins and nitric oxide modulate airway remodeling in a model of lung allergic inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 578s Year: 2005 Novel concepts in airway inflammation and remodelling in asthma Source: Eur Respir J 2015; 46: 1796-1804 Year: 2015 Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD Source: Eur Respir J 2011; 38: 789-796 Year: 2011 Airway remodelling in asthma is related to particular characteristics of airway inflammation Source: Eur Respir J 2002; 20: Suppl. 38, 188s Year: 2002 Glucagon inhibits airway hyperreactivity and lung inflammation in a murine model of acute lung injury Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 The role of CCR5 in allergen-induced airway hyperresponsiveness and airway inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009